Reify Health Raises $30 Million to Integrate Clinical Trials Into the Global Healthcare System

Aug 12, 2020•over 5 years ago

Amount Raised

$30 Million

Boston

Description

Reify Health, provider of leading cloud-based solutions that connect and empower the clinical trial ecosystem, today announced a $30 million Series B funding round led by Battery Ventures. Reify developed its platform, StudyTeam, to upgrade the systems that healthcare staff at clinical research sites depend on to run trials. By bringing them onto a shared platform with biopharma sponsors, Reify has helped the industry dramatically accelerate clinical trial enrollment and reduce workloads for stakeholders across the ecosystem.

Company Information

Company

Reify Health

Location

Boston, Massachusetts, United States

About

Reify Health paves the way to faster, predictable, and more accessible clinical trials. Through its business entities, StudyTeam and Care Access, the company provides best-in-class clinical optimization software, with a focus on effective enrollment, and transformative clinical trial infrastructure that delivers research directly to more healthcare providers, communities, and patients wherever they are. Through partnerships with top biopharma companies, leading healthcare organizations, and thousands of research sites worldwide, Reify Health eliminates delays in drug development one trial at a time. To find out how Reify Health makes clinical research better, faster, and more collaborative, visit www.reifyhealth.com.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Reify Health Raises $30 Million to Integrate Clinical Trials Into the Global Healthcare System

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information